During the past decade, North Carolina Children's Hospital: Department of Pediatrics, Division of Allergy, Immunology and Rheumatology conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "North Carolina Children's Hospital: Department of Pediatrics, Division of Allergy, Immunology and Rheumatology" #1 collaborator was "Rho Federal Systems Division, Inc." with 2 trials as a collaborator, "Consortium for Food Allergy Research" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator and "Novartis Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "North Carolina Children's Hospital: Department of Pediatrics, Division of Allergy, Immunology and Rheumatology" are "Atopic Dermatitis" (2 trials), "Allergic Diseases" (1 trials), "Food Allergy" (1 trials), "Multi-food Allergy" (1 trials) and "Peanut Allergy" (1 trials). Many other conditions were trialed in "North Carolina Children's Hospital: Department of Pediatrics, Division of Allergy, Immunology and Rheumatology" in a lesser frequency.

Most popular intervention types in "North Carolina Children's Hospital: Department of Pediatrics, Division of Allergy, Immunology and Rheumatology" are "Drug" (2 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Double-Blind Placebo-Controlled Food Challenge Based Treatment" (1 trials), "Dupilumab" (1 trials), "Multi-Allergen Oral Immunotherapy" (1 trials), "Omalizumab" (1 trials) and "Placebo for Multi-Allergen Oral Immunotherapy" (1 trials). Other intervention names were less common.

The vast majority of trials in "North Carolina Children's Hospital: Department of Pediatrics, Division of Allergy, Immunology and Rheumatology" are 3 trials for "All" genders.

Currently, there are NaN active trials in "North Carolina Children's Hospital: Department of Pediatrics, Division of Allergy, Immunology and Rheumatology". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in North Carolina Children's Hospital: Department of Pediatrics, Division of Allergy, Immunology and Rheumatology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in North Carolina Children's Hospital: Department of Pediatrics, Division of Allergy, Immunology and Rheumatology, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".